Opportunistic Infections Citation List: October 25 - November 7, 2013
ANTIFUNGAL COMPOUNDS (includes Cryptococcus, Aspergillus, Candida, & Histoplasma)
1. Synthesis and Evaluation of (Z)-2,3-Diphenylacrylonitrile Analogs as Anti-cancer and Anti-microbial Agents. Alam, M.S., Y.J. Nam, and D.U. Lee. European Journal of Medicinal Chemistry, 2013. 69: p. 790-797. PMID[24113364].
[PubMed]. OI_1025-110713.
2. 1-Aryl-3-(1H-imidazol-1-yl)propan-1-ol Esters: Synthesis, Anti-candida Potential and Molecular Modeling Studies. Attia, M.I., A.A. Radwan, A.S. Zakaria, M.S. Almutairi, and S.W. Ghoneim. Chemistry Central Journal, 2013. 7(1): p. 168. PMID[24156656].
[PubMed]. OI_1025-110713.
3. Antimicrobial Activity and Cytotoxicity of the Ethanol Extract, Fractions and Eight Compounds Isolated from Eriosema robustum (Fabaceae). Awouafack, M.D., L.J. McGaw, S. Gottfried, R. Mbouangouere, P. Tane, M. Spiteller, and J.N. Eloff. BMC Complementary and Alternative Medicine, 2013. 13(1): p. 289. PMID[24165199].
[PubMed]. OI_1025-110713.
4. Antifungal Activity of 10 Guadeloupean Plants. Biabiany, M., V. Roumy, T. Hennebelle, N. Francois, B. Sendid, M. Pottier, M. Aliouat el, I. Rouaud, F. Lohezic-Le Devehat, H. Joseph, P. Bourgeois, S. Sahpaz, and F. Bailleul. Phytotherapy Research, 2013. 27(11): p. 1640-1645. PMID[23280633].
[PubMed]. OI_1025-110713.
5. Clinical Features of Patients with Infections Caused by Candida guilliermondii and Candida fermentati and Antifungal Susceptibility of the Isolates at a Medical Centre in Taiwan, 2001-10. Chen, C.Y., S.Y. Huang, J.L. Tang, W. Tsay, M. Yao, B.S. Ko, W.C. Chou, H.F. Tien, and P.R. Hsueh. The Journal of Antimicrobial Chemotherapy, 2013. 68(11): p. 2632-2635. PMID[23766486].
[PubMed]. OI_1025-110713.
6. Antifungal Effect and Pore-forming Action of Lactoferricin B Like Peptide Derived from Centipede Scolopendra subspinipes Mutilans. Choi, H., J.S. Hwang, and D.G. Lee. Biochimica et Biophysica Acta, 2013. 1828(11): p. 2745-2750. PMID[23896552].
[PubMed]. OI_1025-110713.
7. In Vitro Susceptibility of Aspergillus fumigatus to Isavuconazole: Correlation with Itraconazole, Voriconazole, and Posaconazole. Gregson, L., J. Goodwin, A. Johnson, L. McEntee, C.B. Moore, M. Richardson, W.W. Hope, and S.J. Howard. Antimicrobial Agents and Chemotherapy, 2013. 57(11): p. 5778-5780. PMID[24041890].
[PubMed]. OI_1025-110713.
8. Determination of Isavuconazole Susceptibility of Aspergillus and Candida Species by the Eucast Method. Howard, S.J., C. Lass-Florl, M. Cuenca-Estrella, A. Gomez-Lopez, and M.C. Arendrup. Antimicrobial Agents and Chemotherapy, 2013. 57(11): p. 5426-5431. PMID[23959309].
[PubMed]. OI_1025-110713.
9. Intermolecular Interaction of Voriconazole Analogues with Model Membrane by DSC and NMR, and Their Antifungal Activity Using NMR Based Metabolic Profiling. Kalamkar, V., M. Joshi, V. Borkar, S. Srivastava, and M. Kanyalkar. Bioorganic & Medicinal Chemistry, 2013. 21(21): p. 6753-6762. PMID[24012381].
[PubMed]. OI_1025-110713.
10. In Vitro Synergistic Activity of Diketopiperazines Alone and in Combination with Amphotericin B or Clotrimazole against Candida albicans. Kumar, S.N., B. Nambisan, C. Mohandas, and A. Sundaresan. Folia Microbiologica, 2013. 58(6): p. 475-482. PMID[23446490].
[PubMed]. OI_1025-110713.
11. Guanylated Polymethacrylates: A Class of Potent Antimicrobial Polymers with Low Hemolytic Activity. Locock, K.E., T.D. Michl, J.D. Valentin, K. Vasilev, J.D. Hayball, Y. Qu, A. Traven, H.J. Griesser, L. Meagher, and M. Haeussler. Biomacromolecules, 2013. [Epub ahead of print]. PMID[24099527].
[PubMed]. OI_1025-110713.
12. Antimicrobial, Antioxidant and Anti-inflammatory Activity of Young Shoots of the Smoke Tree, Cotinus Coggygria scop. Marcetic, M., D. Bozic, M. Milenkovic, N. Malesevic, S. Radulovic, and N. Kovacevic. Phytotherapy Research, 2013. 27(11): p. 1658-1663. PMID[23280933].
[PubMed]. OI_1025-110713.
13. Mechanism of Action of Novel Synthetic Dodecapeptides against Candida albicans. Maurya, I.K., C.K. Thota, J. Sharma, S.G. Tupe, P. Chaudhary, M.K. Singh, I.S. Thakur, M. Deshpande, R. Prasad, and V.S. Chauhan. Biochimica et Biophysica Acta, 2013. 1830(11): p. 5193-5203. PMID[23876294].
[PubMed]. OI_1025-110713.
14. Antifungal Activity of Silver Nanoparticles in Combination with Nystatin and Chlorhexidine Digluconate against Candida albicans and Candida glabrata Biofilms. Monteiro, D.R., S. Silva, M. Negri, L.F. Gorup, E.R. de Camargo, R. Oliveira, D.B. Barbosa, and M. Henriques. Mycoses, 2013. 56(6): p. 672-680. PMID[23773119].
[PubMed]. OI_1025-110713.
15. Synthetic Analogs of Anoplin Show Improved Antimicrobial Activities. Munk, J.K., L.E. Uggerhoj, T.J. Poulsen, N. Frimodt-Moller, R. Wimmer, N.T. Nyberg, and P.R. Hansen. Journal of Peptide Science, 2013. 19(11): p. 669-675. PMID[24019229].
[PubMed]. OI_1025-110713.
16. Screening of Microbial Contamination and Antimicrobial Activity of Sea Cucumber Holothuria polii. Omran, N.E. and N.G. Allam. Toxicology and Industrial Health, 2013. 29(10): p. 944-954. PMID[22653870].
[PubMed]. OI_1025-110713.
17. Microwave Assisted Synthesis of Dihydrobenzo[4,5]imidazo[1,2-a]pyrimidin-4-ones; Synthesis, in Vitro Antimicrobial and Anticancer Activities of Novel Coumarin Substituted Dihydrobenzo[4,5]imidazo[1,2-a]pyrimidin-4-ones. Puttaraju, K.B., K. Shivashankar, Chandra, M. Mahendra, V.P. Rasal, P.N. Venkata Vivek, K. Rai, and M.B. Chanu. European Journal of Medicinal Chemistry, 2013. 69: p. 316-322. PMID[24056147].
[PubMed]. OI_1025-110713.
18. Antifungal Cyclic Lipopeptides from Bacillus amyloliquefaciens Strain BO5A. Romano, A., D. Vitullo, M. Senatore, G. Lima, and V. Lanzotti. Journal of Natural Products, 2013. [Epub ahead of print]. PMID[24164115].
[PubMed]. OI_1025-110713.
19. Photodynamic Antimicrobial Chemotherapy (PACT) Inhibits Biofilm Formation by Candida albicans, Increasing Both ROS Production and Membrane Permeability. Rosseti, I.B., L.R. Chagas, and M.S. Costa. Lasers in Medical Science, 2013. [Epub ahead of print]. PMID[24178908].
[PubMed]. OI_1025-110713.
20. Indolo[3,2-a]carbazoles from a Deep-water Sponge of the Genus Asteropus. Russell, F., D. Harmody, P.J. McCarthy, S.A. Pomponi, and A.E. Wright. Journal of Natural Products, 2013. 76(10): p. 1989-1992. PMID[24063539].
[PubMed]. OI_1025-110713.
21. Susceptibility Profile of a Brazilian Yeast Stock Collection of Candida Species Isolated from Subjects with Candida-associated Denture Stomatitis with or without Diabetes. Sanita, P.V., E.G. Mima, A.C. Pavarina, J.H. Jorge, A.L. Machado, and C.E. Vergani. Oral Surgery Oral Medicine Oral Pathology and Oral Radiology, 2013. 116(5): p. 562-569. PMID[24055150].
[PubMed]. OI_1025-110713.
22. Synthesis and Antimicrobial Activity of Polyhalobenzonitrile Quinazolin-4(3H)-one Derivatives. Shi, L.P., K.M. Jiang, J.J. Jiang, Y. Jin, Y.H. Tao, K. Li, X.H. Wang, and J. Lin. Bioorganic & Medicinal Chemistry Letters, 2013. 23(21): p. 5958-5963. PMID[24044873].
[PubMed]. OI_1025-110713.
23. Use of Isothermal Microcalorimetry to Quantify the Influence of Glucose and Antifungals on the Growth of Candida albicans in Urine. Wernli, L., G. Bonkat, T.C. Gasser, A. Bachmann, and O. Braissant. Journal of Applied Microbiology, 2013. 115(5): p. 1186-1193. PMID[23865534].
[PubMed]. OI_1025-110713.
24. Antimicrobial Ergosteroids and Pyrrole Derivatives from Halotolerant Aspergillus flocculosus PT05-1 Cultured in a Hypersaline Medium. Zheng, J., Y. Wang, J. Wang, P. Liu, J. Li, and W. Zhu. Extremophiles, 2013. 17(6): p. 963-971. PMID[24030481].
[PubMed]. OI_1025-110713.
ANTIBACTERIAL COMPOUNDS (includes Mycobacterium spp., Drug Resistant, MAC, MDR)
25. Trimethoprim/Sulfamethoxazole Susceptibility of Mycobacterium tuberculosis. Alsaad, N., T. van der Laan, R. van Altena, K.R. Wilting, T.S. van der Werf, Y. Stienstra, D. van Soolingen, and J.W. Alffenaar. International Journal of Antimicrobial Agents, 2013. 42(5): p. 472-474. PMID[24035198].
[PubMed]. OI_1025-110713.
26. Synthetic Thioamide, Benzimidazole, Quinolone and Derivatives with Carboxylic acid and Ester Moieties. A Strategy in the Design of Antituberculosis Agents. Ashfaq, M., S.S. Shah, T. Najam, M.M. Ahmad, R. Tabassum, and G. Rivera. Current Medicinal Chemistry, 2013. [Epub ahead of print]. PMID[24164193].
[PubMed]. OI_1025-110713.
27. Synthesis, Characterization and in Vitro Biological Evaluation of Some Novel 1,3,5-Triazine-Schiff Base Conjugates as Potential Antimycobacterial Agents. Avupati, V.R., R.P. Yejella, V.R. Parala, K.N. Killari, V.M. Papasani, P. Cheepurupalli, V.R. Gavalapu, and B. Boddeda. Bioorganic & Medicinal Chemistry Letters, 2013. 23(21): p. 5968-5970. PMID[24044875].
[PubMed]. OI_1025-110713.
28. Bactericidal Activity and Mechanism of Action of AZD5847: A Novel Oxazolidinone for the Treatment of Tuberculosis. Balasubramanian, V., S. Solapure, H. Iyer, A. Ghosh, S. Sharma, P. Kaur, R. Deepthi, V. Subbulakshmi, V. Ramya, V. Ramachandran, M. Balganesh, L. Wright, D. Melnick, S.L. Butler, and V.K. Sambandamurthy. Antimicrobial Agents and Chemotherapy, 2013. [Epub ahead of print]. PMID[24189255].
[PubMed]. OI_1025-110713.
29. Current Prospects of Synthetic Curcumin Analogs and Chalcone Derivatives against Mycobacterium tuberculosis. Bukhari, S.N., S.G. Franzblau, I. Jantan, and M. Jasamai. Medicinal Chemistry, 2013. 9(7): p. 897-903. PMID[23305394].
[PubMed]. OI_1025-110713.
30. Sulfonamides Incorporating Fluorine and 1,3,5-Triazine Moieties Are Effective Inhibitors of Three Beta-class Carbonic Anhydrases from Mycobacterium Tuberculosis. Ceruso, M., D. Vullo, A. Scozzafava, and C.T. Supuran. Journal of Enzyme Inhibition and Medicinal Chemistry, 2013. [Epub ahead of print]. PMID[24156740].
[PubMed]. OI_1025-110713.
31. In Vitro Anti-mycobacterial Activity of Selected Medicinal Plants against Mycobacterium tuberculosis and Mycobacterium bovis Strains. Gemechu, A., M. Giday, G. Ameni, and A. Worku. BMC Complementary and Alternative Medicine, 2013. 13(1): p. 291. PMID[24168665].
[PubMed]. OI_1025-110713.
32. Antimycobacterial and Herbicidal Activity of Ring-substituted 1-Hydroxynaphthalene-2-carboxanilides. Gonec, T., J. Kos, I. Zadrazilova, M. Pesko, S. Keltosova, J. Tengler, P. Bobal, P. Kollar, A. Cizek, K. Kralova, and J. Jampilek. Bioorganic & Medicinal Chemistry, 2013. 21(21): p. 6531-6541. PMID[24075143].
[PubMed]. OI_1025-110713.
33. 2-(2-Hydrazinyl)thiazole Derivatives: Design, Synthesis and in Vitro Antimycobacterial Studies. Makam, P., R. Kankanala, A. Prakash, and T. Kannan. European Journal of Medicinal Chemistry, 2013. 69: p. 564-576. PMID[24095750].
[PubMed]. OI_1025-110713.
34. Studies on Substituted Benzo[h]quinazolines, Benzo[g]indazoles, Pyrazoles, 2,6-Diarylpyridines as Anti-tubercular Agents. Maurya, H.K., R. Verma, S. Alam, S. Pandey, V. Pathak, S. Sharma, K.K. Srivastava, A.S. Negi, and A. Gupta. Bioorganic & Medicinal Chemistry Letters, 2013. 23(21): p. 5844-5849. PMID[24074842].
[PubMed]. OI_1025-110713.
35. Structure-Activity Relationships of 2-Aminothiazoles Effective against Mycobacterium tuberculosis. Meissner, A., H.I. Boshoff, M. Vasan, B.P. Duckworth, C.E. Barry, 3rd, and C.C. Aldrich. Bioorganic & Medicinal Chemistry, 2013. 21(21): p. 6385-6397. PMID[24075144].
[PubMed]. OI_1025-110713.
36. Synthesis and Evaluation of alpha-Ketotriazoles and alpha, beta-Diketotriazoles as Inhibitors of Mycobacterium tuberculosis. Menendez, C., F. Rodriguez, A.L. Ribeiro, F. Zara, C. Frongia, V. Lobjois, N. Saffon, M.R. Pasca, C. Lherbet, and M. Baltas. European Journal of Medicinal Chemistry, 2013. 69: p. 167-173. PMID[24016834].
[PubMed]. OI_1025-110713.
37. Manganese(II) Complexes with Thiosemicarbazones as Potential anti-Mycobacterium tuberculosis Agents. Oliveira, C.G., P.I. Maia, P.C. Souza, F.R. Pavan, C.Q. Leite, R.B. Viana, A.A. Batista, O.R. Nascimento, and V.M. Deflon. Journal of Inorganic Biochemistry, 2013. [Epub ahead of print]. PMID[24188534].
[PubMed]. OI_1025-110713.
38. New Derivatives of Salicylamides: Preparation and Antimicrobial Activity against Various Bacterial Species. Pauk, K., I. Zadrazilova, A. Imramovsky, J. Vinsova, M. Pokorna, M. Masarikova, A. Cizek, and J. Jampilek. Bioorganic & Medicinal Chemistry, 2013. 21(21): p. 6574-6581. PMID[24045008].
[PubMed]. OI_1025-110713.
39. Development of 3-Phenyl-4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridine Derivatives as Novel Mycobacterium tuberculosis Pantothenate Synthetase Inhibitors. Samala, G., P.B. Devi, R. Nallangi, P. Yogeeswari, and D. Sriram. European Journal of Medicinal Chemistry, 2013. 69: p. 356-364. PMID[24077526].
[PubMed]. OI_1025-110713.
ANTIMALARIAL COMPOUNDS (Plasmodium spp.)
40. Antimalarial Screening Via Large-scale Purification of Plasmodium falciparum Ca(2+) -ATPase 6 and in Vitro Studies. David-Bosne, S., I. Florent, A.M. Lund-Winther, J.B. Hansen, M. Buch-Pedersen, P. Machillot, M. le Maire, and C. Jaxel. The FEBS Journal, 2013. 280(21): p. 5419-5429. PMID[23497141].
[PubMed]. OI_1025-110713.
41. Potential Efficacy of Citicoline as Adjunct Therapy in the Treatment of Cerebral Malaria. El-Assaad, F., V. Combes, G.E. Grau, and R. Jambou. Antimicrobial Agents and Chemotherapy, 2013. [Epub ahead of print]. PMID[24165175].
[PubMed]. OI_1025-110713.
42. Synthesis and Antiprotozoal Activity of Dicationic 2,6-Diphenylpyrazines and Aza-analogues. Hu, L., A. Patel, L. Bondada, S. Yang, M.Z. Wang, M. Munde, W.D. Wilson, T. Wenzler, R. Brun, and D.W. Boykin. Bioorganic & Medicinal Chemistry, 2013. 21(21): p. 6732-6741. PMID[24012380].
[PubMed]. OI_1025-110713.
43. In Vitro Antimalarial Activity, beta-Haematin Inhibition and Structure-Activity Relationships in a Series of Quinoline triazoles. Joshi, M.C., K.J. Wicht, D. Taylor, R. Hunter, P.J. Smith, and T.J. Egan. European Journal of Medicinal Chemistry, 2013. 69: p. 338-347. PMID[24077524].
[PubMed]. OI_1025-110713.
44. Synergy of Ferrous Ion on 5-Aminolevulinic acid Mediated Growth Inhibition of Plasmodium falciparum. Komatsuya, K., M. Hata, E.O. Balogun, K. Hikosaka, S. Suzuki, K. Takahashi, T. Tanaka, M. Nakajima, S.I. Ogura, S. Sato, and K. Kita. Journal of Biochemistry, 2013. [Epub ahead of print]. PMID[24158489].
[PubMed]. OI_1025-110713.
45. Imidazopyridazines as Potent Inhibitors of Plasmodium falciparum Calcium-dependent Protein Kinase 1 (PFCDPK1): Preparation and Evaluation of Pyrazole Linked Analogues. Large, J.M., S.A. Osborne, E. Smiljanic-Hurley, K.H. Ansell, H.M. Jones, D.L. Taylor, B. Clough, J.L. Green, and A.A. Holder. Bioorganic & Medicinal Chemistry Letters, 2013. 23(21): p. 6019-6024. PMID[24035097].
[PubMed]. OI_1025-110713.
46. Synthesis and in Vitro and in Vivo Evaluation of Antimalarial Polyamines. Liew, L.P., A.N. Pearce, M. Kaiser, and B.R. Copp. European Journal of Medicinal Chemistry, 2013. 69: p. 22-31. PMID[23995215].
[PubMed]. OI_1025-110713.
47. Transdermal Glyceryl trinitrate as an Effective Adjunctive Treatment with Artemether for Late-stage Experimental Cerebral Malaria. Orjuela-Sanchez, P., P.K. Ong, G.M. Zanini, B. Melchior, Y.C. Martins, D. Meays, J.A. Frangos, and L.J. Carvalho. Antimicrobial Agents and Chemotherapy, 2013. 57(11): p. 5462-5471. PMID[23979751].
[PubMed]. OI_1025-110713.
48. Squaric acid/4-Aminoquinoline Conjugates: Novel Potent Antiplasmodial Agents. Ribeiro, C.J., S.P. Kumar, J. Gut, L.M. Goncalves, P.J. Rosenthal, R. Moreira, and M.M. Santos. European Journal of Medicinal Chemistry, 2013. 69: p. 365-372. PMID[24077527].
[PubMed]. OI_1025-110713.
49. Flavones as Isosteres of 4(1H)-Quinolones: Discovery of Ligand Efficient and Dual Stage Antimalarial Lead Compounds. Rodrigues, T., A.S. Ressurreicao, F.P. da Cruz, I.S. Albuquerque, J. Gut, M.P. Carrasco, D. Goncalves, R.C. Guedes, D.J. Dos Santos, M.M. Mota, P.J. Rosenthal, R. Moreira, M. Prudencio, and F. Lopes. European Journal of Medicinal Chemistry, 2013. 69: p. 872-880. PMID[24125849].
[PubMed]. OI_1025-110713.
50. Antiparasitic Effect of a Fraction Enriched in Tight-binding Protease Inhibitors Isolated from the Caribbean Coral Plexaura homomalla. Salas-Sarduy, E., A. Cabrera-Munoz, A. Cauerhff, Y. Gonzalez-Gonzalez, S.A. Trejo, A. Chidichimo, L. Chavez-Planes Mde, and J.J. Cazzulo. Experimental Parasitology, 2013. 135(3): p. 611-622. PMID[24090569].
[PubMed]. OI_1025-110713.
51. Synthesis, Characterization, Antiparasitic and Cytotoxic Evaluation of Thioureas Conjugated to Polyamine Scaffolds. Stringer, T., D. Taylor, C. de Kock, H. Guzgay, A. Au, S.H. An, B. Sanchez, R. O'Connor, N. Patel, K.M. Land, P.J. Smith, D.T. Hendricks, T.J. Egan, and G.S. Smith. European Journal of Medicinal Chemistry, 2013. 69: p. 90-98. PMID[24012713].
[PubMed]. OI_1025-110713.
52. Chemical Investigation of an Antimalarial Chinese Medicinal Herb Picrorhiza scrophulariiflora. Wang, H., W. Zhao, V. Choomuenwai, K.T. Andrews, R.J. Quinn, and Y. Feng. Bioorganic & Medicinal Chemistry Letters, 2013. 23(21): p. 5915-5918. PMID[24035096].
[PubMed]. OI_1025-110713.
ANTIPROTOZOAL COMPOUNDS
53. In Vitro Effects of Novel Ruthenium Complexes in Neospora caninum and Toxoplasma gondii Tachyzoites. Barna, F., K. Debache, C.A. Vock, T. Kuster, and A. Hemphill. Antimicrobial Agents and Chemotherapy, 2013. 57(11): p. 5747-5754. PMID[23979747].
[PubMed]. OI_1025-110713.
54. Design, Synthesis and Biological Evaluation of WC-9 Analogs as Antiparasitic Agents. Elicio, P.D., M.N. Chao, M. Galizzi, C. Li, S.H. Szajnman, R. Docampo, S.N. Moreno, and J.B. Rodriguez. European Journal of Medicinal Chemistry, 2013. 69: p. 480-489. PMID[24090919].
[PubMed]. OI_1025-110713.
Citations from the ISI Web of Knowledge Listings for O.I.
55. Effect of Jujube Honey on Candida albicans Growth and Biofilm Formation. Ansari, M.J., A. Al-Ghamdi, S. Usmani, N.S. Al-Waili, D. Sharma, A. Nuru, and Y. Al-Attal. Archives of Medical Research, 2013. 44(5): p. 352-360. ISI[000324847900004].
[WOS]. OI_1025-110713.
56. A Novel Calcium-dependent Protein Kinase Inhibitor as a Lead Compound for Treating Cryptosporidiosis. Castellanos-Gonzalez, A., A.C. White, K.K. Ojo, R.S.R. Vidadala, Z.S. Zhang, M.C. Reid, A.M.W. Fox, K.R. Keyloun, K. Rivas, A. Irani, S.M. Dann, E.K. Fan, D.J. Maly, and W.C. Van Voorhis. Journal of Infectious Diseases, 2013. 208(8): p. 1342-1348. ISI[000324832800020].
[WOS]. OI_1025-110713.
57. Synthesis and Antifungal Activity of Terpenyl-1,4-naphthoquinone and 1,4-Anthracenedione Derivatives. Castro, M.A., A.M. Gamito, V. Tangarife-Castatno, B. Zapata, J.M.M. del Corral, A.C. Mesa-Arango, L. Betancur-Galvis, and A. San Feliciano. European Journal of Medicinal Chemistry, 2013. 67: p. 19-27. ISI[000325121800003].
[WOS]. OI_1025-110713.
58. Exploration of Antimicrobial Potential of Pyrazolo[3,4-b]pyridine Scaffold Bearing Benzenesulfonamide and Trifluoromethyl Moieties. Chandak, N., S. Kumar, P. Kumar, C. Sharma, K.R. Aneja, and P.K. Sharma. Medicinal Chemistry Research, 2013. 22(11): p. 5490-5503. ISI[000325076400039].
[WOS]. OI_1025-110713.
59. Green Approach Towards Synthesis of Substituted Pyrazole-1,4-dihydro,9-oxa,1,2,6,8-tetrazacyclopentano[b]naphthalene-5-one Derivatives as Antimycobacterial Agents. Chobe, S.S., R.D. Kamble, S.D. Patil, A.P. Acharya, S.V. Hese, O.S. Yemul, and B.S. Dawane. Medicinal Chemistry Research, 2013. 22(11): p. 5197-5203. ISI[000325076400010].
[WOS]. OI_1025-110713.
60. Synthesis and Antimycobacterial Activity of Analogues of the Bioactive Natural Products Sampangine and Cleistopholine. Claes, P., D. Cappoen, B.M. Mbala, J. Jacobs, B. Mertens, V. Mathys, L. Verschaeve, K. Huygen, and N. De Kimpe. European Journal of Medicinal Chemistry, 2013. 67: p. 98-110. ISI[000325121800012].
[WOS]. OI_1025-110713.
61. Synthesis of Quinoline-Pyrazoline Based Thiazole Derivatives Endowed with Antimicrobial Activity. Desai, N.C., V.V. Joshi, K.M. Rajpara, H.V. Vaghani, and H.M. Satodiya. Indian Journal of Chemistry Section B - Organic Chemistry Including Medicinal Chemistry, 2013. 52(9): p. 1191-1201. ISI[000324658000001].
[WOS]. OI_1025-110713.
62. Synthesis, Characterization, and Thermal and Antimicrobial Activities of Some Novel Organotin(IV): Purine Base Complexes. Jain, R., R. Singh, and N.K. Kaushik. Journal of Chemistry, 2013. 568195: p. 12. ISI[000324946600001].
[WOS]. OI_1025-110713.
63. Purification, Molecular Cloning, and Antimicrobial Activity of Peptides from the Skin Secretion of the Black-Spotted Frog, Rana nigromaculata. Li, A., Y. Zhang, C. Wang, G. Wu, and Z.C. Wang. World Journal of Microbiology & Biotechnology, 2013. 29(10): p. 1941-1949. ISI[000325035100022].
[WOS]. OI_1025-110713.
64. The Antimycobacterial MICs, SARs, and QSARs of Some Ethnobotanically Selected Phytocompounds. Muriuki, B., J.O. Midiwo, P.M. Mbugua, and J.M. Keriko. Medicinal Chemistry Research, 2013. 22(11): p. 5141-5152. ISI[000325076400006].
[WOS]. OI_1025-110713.
65. In Vitro Antimicrobial Activity of Total Extracts of the Leaves of Petiveria alliacea L. (Anamu). Pacheco, A.O., J.M. Moran, Z.G. Giro, A.H. Rodriguez, R.J. Mujawimana, K.T. Gonzalez, and S.S. Frometa. Brazilian Journal of Pharmaceutical Sciences, 2013. 49(2): p. 241-250. ISI[000324586900006].
[WOS]. OI_1025-110713.
66. Metal Complexes of Moxifloxacin-imidazole Mixed Ligands: Characterization and Biological Studies. Soayed, A.A., H.M. Refaat, and D.A.N. El-Din. Inorganica Chimica Acta, 2013. 406: p. 230-240. ISI[000324325200032].
[WOS]. OI_1025-110713.
67. Antifungal Susceptibility, Exoenzyme Production and Cytotoxicity of Novel Oximes against Candida. Souza, J.L.S., F. Nedel, M. Ritter, P.H.A. Carvalho, C.M.P. Pereira, and R.G. Lund. Mycopathologia, 2013. 176(3-4): p. 201-210. ISI[000325135500004].
[WOS]. OI_1025-110713.
68. Evaluation of the Effect of Cassia surattensis Burm. f., Flower Methanolic Extract on the Growth and Morphology of Aspergillus niger. Sumathy, V., Z. Zakaria, Y. Chen, L.Y. Latha, S.L. Jothy, S. Vijayarathna, and S. Sasidharan. European Review for Medical and Pharmacological Sciences, 2013. 17(12): p. 1648-1654. ISI[000324924200014].
[WOS]. OI_1025-110713.
69. Synthesis and Biological Evaluation of Acyclic Phosphonic acid Nucleoside Derivatives. Wainwright, P., A. Maddaford, X.R. Zhang, H. Billington, D. Leese, R. Glen, D.C. Pryde, D.S. Middleton, P.T. Stephenson, and S. Sutton. Nucleosides, Nucleotides & Nucleic Acids, 2013. 32(9): p. 477-492. ISI[000324977900001].
[WOS]. OI_1025-110713.
70. Synthesis and Fungicidal Evaluation of Some New Anilinopyrimidine Derivatives. Waly, M.A., E.T. Bader-Eldien, M.E. Aboudobarah, and E.T. Aboumosalam. Medicinal Chemistry Research, 2013. 22(11): p. 5267-5273. ISI[000325076400017].
[WOS]. OI_1025-110713.
71. Synthesis and in Vitro Antimicrobial Activity of Novel 2-(4-(Substituted-carboxamido)benzyl/phenyl)benzothiazoles. Yilmaz, S., I. Yalcin, F. Kaynak-Onurdag, S. Ozgen, I. Yildiz, and E. Aki. Croatica Chemica Acta, 2013. 86(2): p. 223-231. ISI[000324850500013].
[WOS]. OI_1025-110713.